Login
$DUKR
$4.19 +$0.14 (3.46%) Close

Unaudited Condensed Consolidated Interim Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Current Assets
Cash and cash equivalents
Restricted Cash
Trade receivables
Other current assets
Total Current assets
Right-of-use asset arising from operating leases and other lease deposit
Operating lease right-of-use asset and lease deposit
Property and equipment, net
Total assets
Current Liabilities
Accounts payable
Operating lease liability
Other liabilities
Stock purchase warrants liability
Total current liabilities
Related parties loans
Operating lease liability
Total liabilities
Stockholders’ Equity
Common stock of US$ 0.0001 par value each (“Common Stock”): 350,000,000 shares authorized as of June 30, 2026 and December 31, 2025; issued and outstanding 3,407,978 and 2,177,045 shares as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Foreign currency translation adjustments
Accumulated deficit
Total stockholders’ Equity
Total liabilities and stockholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support